content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: OrbiMed Advisors II Ltd -->
            <cik>0001968251</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001944885</issuerCik>
        <issuerName>Apollomics Inc.</issuerName>
        <secFileNumber>001-41670</secFileNumber>
        <issuerAddress>
          <com:street1>989 E. Hillsdale Blvd.</com:street1>
          <com:street2>Suite 220</com:street2>
          <com:city>Foster City</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94404</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>650-209-4055</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OrbiMed Asia Partners II, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Class A Ordinary Shares</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Morgan Stanley</name>
          <address>
            <com:street1>1585 Broadway</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10036</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>9515756</noOfUnitsSold>
        <aggregateMarketValue>11323750.00</aggregateMarketValue>
        <noOfUnitsOutstanding>89480790</noOfUnitsOutstanding>
        <approxSaleDate>11/27/2023</approxSaleDate>
        <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Class A ordinary shares</securitiesClassTitle>
        <acquiredDate>03/29/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Business combination</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>9515756</amountOfSecuritiesAcquired>
        <paymentDate>03/29/2023</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>OrbiMed Asia GP II, L.P.</name>
          <address>
            <com:street1>601 Lexington Ave.</com:street1>
            <com:street2>54th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Class A ordinary shares</securitiesClassTitle>
        <saleDate>11/16/2023</saleDate>
        <amountOfSecuritiesSold>6700000</amountOfSecuritiesSold>
        <grossProceeds>8375000.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>OrbiMed Asia GP II, L.P. is the general partner of OrbiMed Asia Partners II, L.P., and OrbiMed Advisors II Limited is the genernal partner of OrbiMed Asia GP II, L.P. OrbiMed Advisors LLC is the advisory company of OrbiMed Asia Partners II, L.P.</remarks>
      <noticeSignature>
        <noticeDate>11/27/2023</noticeDate>
        <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors II Limited, general partner of the general partner of OrbiMed Asia Partners II, L.P.</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3944}]
text: 144
  0001968251
  XXXXXXXX
  LIVE
  0001944885
  Apollomics Inc.
  001-41670
  989 E. Hillsdale Blvd.
  Suite 220
  Foster City
  CA
  94404
  650-209-4055
  OrbiMed Asia Partners II, L.P.
  Shareholder
  Class A Ordinary Shares
  Morgan Stanley
  1585 Broadway
  New York
  NY
  10036
  9515756
  11323750.00
  89480790
  11/27/2023
  Nasdaq Stock Market
  Class A ordinary shares
  03/29/2023
  Business combination
  Issuer
  N
  9515756
  03/29/2023
  Cash
  N
  OrbiMed Asia GP II, L.P.
  601 Lexington Ave.
  54th Floor
  New York
  NY
  10022
  Class A ordinary shares
  11/16/2023
  6700000
  8375000.00
  OrbiMed Asia GP II, L.P. is the general partner of OrbiMed Asia Partners II, L.P., and OrbiMed Advisors II Limited is the genernal partner of OrbiMed Asia GP II, L.P. OrbiMed Advisors LLC is the advisory company of OrbiMed Asia Partners II, L.P.
  11/27/2023
  /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors II Limited, general partner of the general partner of OrbiMed Asia Partners II, L.P.